Literature DB >> 15328154

NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Jeyarani Regunathan1, Yuhong Chen, Demin Wang, Subramaniam Malarkannan.   

Abstract

Interaction of the activating ligand H60 with NKG2D receptor constitutes a major stimulatory pathway for natural killer (NK) cells. The influence of inhibitory Ly49 receptors on NKG2D-mediated activation is not clearly understood. Here we show that the magnitude of NKG2D-mediated cytotoxicity is directly proportional to both the levels of H60 and the nature of major histocompatibility complex (MHC) class I molecules expressed on the target cells. The expression levels of H60 on the target cells determined the extent to which the inhibition by Ly49C/I receptors can be overridden. In contrast, even a higher expression of H60 molecule on the target cells failed to overcome the inhibition mediated by Ly49A/G receptors. Also, the level of interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GM-CSF) generated by NK cells through anti-NKG2D monoclonal antibody (mAb)-mediated activation is significantly reduced by the presence of immobilized anti-Ly49A/G mAbs. Thus, NKG2D-mediated cytotoxicity and cytokine secretion results from the fine balance between activating and inhibitory receptors, thereby defining the NK cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328154      PMCID: PMC3889208          DOI: 10.1182/blood-2004-03-1075

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b).

Authors:  Julie Dam; Rongjin Guan; Kannan Natarajan; Nazzareno Dimasi; Lukasz K Chlewicki; David M Kranz; Peter Schuck; David H Margulies; Roy A Mariuzza
Journal:  Nat Immunol       Date:  2003-11-02       Impact factor: 25.606

3.  A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Authors:  Andreas Diefenbach; Jennifer K Hsia; Ming-Yu B Hsiung; David H Raulet
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

4.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.

Authors:  A Diefenbach; E R Jensen; A M Jamieson; D H Raulet
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

5.  Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo.

Authors:  A Cerwenka; J L Baron; L L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

Review 6.  The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.

Authors:  C L Sutherland; N J Chalupny; D Cosman
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

7.  Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection.

Authors:  Brigitte G Dorner; Hamish R C Smith; Anthony R French; Sungjin Kim; Jennifer Poursine-Laurent; Diana L Beckman; Jeanette T Pingel; Richard A Kroczek; Wayne M Yokoyama
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

Review 8.  Acquisition of MHC-specific receptors on murine natural killer cells.

Authors:  Linnea L Veinotte; Brian T Wilhelm; Dixie L Mager; Fumio Takei
Journal:  Crit Rev Immunol       Date:  2003       Impact factor: 2.214

9.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

10.  Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells.

Authors:  Motoi Maeda; Naoyuki Uchida; Connie J Eaves; Fumio Takei
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084

View more
  24 in total

Review 1.  The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Authors:  Subramaniam Malarkannan
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

2.  Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.

Authors:  Arash Nanbakhsh; Brad Best; Matthew Riese; Sridhar Rao; Li Wang; Jeffrey Medin; Monica S Thakar; Subramaniam Malarkannan
Journal:  J Vis Exp       Date:  2018-01-15       Impact factor: 1.355

Review 3.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.

Authors:  Janelle A Olson; Dennis B Leveson-Gower; Saar Gill; Jeanette Baker; Andreas Beilhack; Robert S Negrin
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  Transforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production.

Authors:  Kamalakannan Rajasekaran; Haiyan Chu; Pawan Kumar; Yechen Xiao; Mathew Tinguely; Asanga Samarakoon; Tae Whan Kim; Xiaoxia Li; Monica S Thakar; Jiwang Zhang; Subramaniam Malarkannan
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

6.  Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.

Authors:  Petter Brodin; Tadepally Lakshmikanth; Ramit Mehr; Maria H Johansson; Adil Doganay Duru; Adnane Achour; Mali Salmon-Divon; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

7.  Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA).

Authors:  M L Molitor-Dart; J Andrassy; L D Haynes; W J Burlingham
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

Review 8.  Murine NKG2D ligands: "double, double toil and trouble".

Authors:  Asanga Samarakoon; Haiyan Chu; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2008-12-10       Impact factor: 4.407

9.  Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells.

Authors:  A Awasthi; A Samarakoon; X Dai; R Wen; D Wang; S Malarkannan
Journal:  Genes Immun       Date:  2008-06-12       Impact factor: 2.676

Review 10.  The NKG2D receptor: immunobiology and clinical implications.

Authors:  Steven J Burgess; Kerima Maasho; Madhan Masilamani; Sriram Narayanan; Francisco Borrego; John E Coligan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.